MENLO PARK, Calif.–(BUSINESS WIRE)–January AI, the precision health company with the first artificial intelligence predicting long-term changes in blood glucose levels, recently announced the addition of Dariush Mozaffarian, M.D., MPH, Dean of the Friedman School of Nutrition Science & Policy at Tufts University to their scientific advisory board. Dr. Mozaffarian joins the SAB at a pivotal moment, with January AI emerging from stealth this summer and releasing their first direct-to-consumer product this Fall.
“We are thrilled to welcome Dr. Mozaffarian to our advisory board and to collaborate closely with the Friedman School at Tufts, particularly in the area of “food as medicine, ” said Noosheen Hashemi, Founder and CEO of January AI. “The SAB will continue to provide January AI with expert advice as we expand our research and development efforts beyond our AI-empowered Season of Me Program to nutraceuticals.”
The SAB is composed of leaders in the fields of medicine, computer science, biology, immunology, genetics and microbiome. They collaborate with the clinical research team- developing state-of-the-art tools to understand how food, activity and other daily stressors impact blood glucose levels in healthy people and individuals with type 2 diabetes and prediabetes and translate these insights into lifestyle modifications and nutraceuticals to improve metabolic health
“With only 12% of American adults being metabolically healthy, we are facing a national catastrophe of preventable human suffering, health disparities, and ever-spiraling healthcare spending,” says Dr. Mozaffarian. “Perhaps more than any other factor, evidence-based good nutrition holds great promise to help us reverse these trends and get back on the path to metabolic health.”
About Dr. Mozaffarian
Dariush Mozaffarian is a cardiologist, Dean, and Jean Mayer Professor at the Tufts Friedman School of Nutrition Science and Policy, and Professor of Medicine at Tufts Medical School. Dr. Mozaffarian has authored more than 400 scientific publications on dietary priorities for obesity, diabetes, and cardiovascular diseases, and on evidence-based policy approaches to reduce these burdens in the US and globally. He has served in numerous advisory roles including for the US and Canadian governments, American Heart Association, World Health Organization, and United Nations. His work has been featured in a wide array of media outlets including the New York Times, Washington Post, Wall Street Journal, National Public Radio, and Time Magazine. In 2016, Thomson Reuters named him as one of the world’s most influential scientific minds.
Dr. Mozaffarian received a BS in biological sciences at Stanford , MD at Columbia, residency training in internal medicine at Stanford, and fellowship training in cardiovascular medicine at the University of Washington. He also received an MPH from the University of Washington and a Doctorate in Public Health from Harvard. Before being appointed as Dean at Tufts in 2014, Dr. Mozaffarian was at Harvard Medical School and Harvard School of Public Health for a decade and clinically active in cardiology at Brigham and Women’s Hospital.
The January AI SAB is led by founder Noosheen Hashemi, CEO, and co-founder Michael Snyder, PhD (link), The full list of SAB members is as follows:
- Nima Aghaeepour, PhD, Assistant Professor, Stanford School of Medicine. Artificial Intelligence, Machine Learning, and Multiomics Integration for Clinical Immunology (link)
- Ami Bhatt, MD, PhD, Assistant Professor of Medicine and of Genetics, Stanford School of Medicine (link)
- Kirill Karlin, MD, Pathology Resident Harvard Medical School, Co-Founder of Asimov Medical, a rare disease startup, Co-author ‘PathoMaps’ (link)
- Parag Mallick, PhD, Founder at Nautilus Biotechnology and Associate Professor at Stanford University (link)
- Eric Martens, PhD, Associate Professor University of Michigan Medical School Department of Microbiology & Immunology (link)
- Tracey McLaughlin, MD, MS, Professor of Medicine, Stanford School of Medicine, Endocrinology, Gerontology, & Metabolism (link)
- Dariush Mozaffarian, MD, PhD, Dean at the Tufts Friedman School of Nutrition Science and Policy, and Professor of Medicine at Tufts Medical School. (link)
- Dalia Perelman; Diabetes Educator (link)
- Justin Sonnenburg, PhD, Associate Professor of Microbiology & Immunology, Stanford, NIH Director’s Pioneer Award Winner (link)
About January AI:
January AI was founded in 2017 with the recognition that the epidemic of diabetes remains mostly unaddressed and that artificial intelligence (AI) could be used to provide personalized care at scale. January AI is focused on helping the 120 million people on the diabetes spectrum through the multi-omic science of health. By harnessing science, medicine, and machine learning, their advanced AI technology discovers how diabetes affects people differently and provides specific recommendations to move them to a healthier state.
Specifically, their recently announced program, The Season of Me™ applies AI to a mix of biological and behavioral data to deliver radically personalized insights and specific recommendations that drive positive behavioral change for people with metabolic syndrome, including diabetes and pre-diabetes. The program is designed to encourage small lifestyle changes and habit-building that are readily achievable, but add up to a significant improvement in one’s health. To learn more about January AI please visit January.ai